Phoqus Limited Gets IND for Chronocort in USA; Sees Drug Marketed from Q1 2009

LONDON (Thomson Financial) - Phoqus Group PLC said it has received Investigational New Drug status from US Food Drug and Administration for its lead product Chronocort and added it has begun a Phase II clinical trial for the drug in patients with cortisol deficiency and androgen excess.

Back to news